Shashank Ponugoti, MD
Internal Medicine · Morgantown, WVNPI 1205085651
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (49.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Gilead accounts for 61.0% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2023 at $4,440 and has fallen 82.4% since, to $781 in 2024. Among internal medicine clinicians in WV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 78 payments — averaging $101.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$5K
- Johnson & Johnson$830
- Inari Medical, Inc.$578
- AstraZeneca$557
- Pfizer$306
- AbbVie$173
- plus $627 from 9 others
What the payments were for
- Consulting fees$3,50044%
- Travel & lodging$4586%
- Food & beverage$3,92150%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 15 | $4,806 |
| Johnson & Johnson | 18 | $830 |
| Inari Medical, Inc. | 8 | $578 |
| AstraZeneca(2 entities) | 7 | $557 |
| Pfizer | 6 | $306 |
| AbbVie(2 entities) | 6 | $173 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $169 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $126 |
| E.r. Squibb & Sons, L.L.C. | 4 | $71 |
| Stryker | 1 | $61 |
| Boehringer Ingelheim | 2 | $58 |
| Abbott | 1 | $57 |
| CSL Behring | 2 | $34 |
| Rigel Pharmaceuticals, Inc. | 1 | $25 |
| Portola Pharmaceuticals, LLC | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Veklury$4,385
- FLOWTRIEVER CATHETER, S$401
- CT THROMBECTOMY SYSTEM KIT$401
- XARELTO$351
- BRILINTA$246
- VYNDAQEL$240
- DALVANCE$125
- AIRSUPRA$123
- ULTOMIRIS$121
- XIFAXAN$103
How this compares
$7,878 in reported general payments places this provider in the 90th percentile of 573 internal medicine providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 24 | $248 |
| Furosemide | 11 | $31 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Morgantown
- Ward PaineMorgantown$6K
- Ameenjamal AhmedMorgantown$5K
- Gabriella HorvathMorgantown$4K
- William ChapmanCharleston$1.7M
- David PickeringParkersburg$599K
- Govind PatelFairmont$59K
- Bisher MustafaHuntington$28K
- Johny AlencherryMartinsburg$27K
- Ali KhanBuckhannon$21K
- Joseph HashemBerkeley Springs$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.